Australia is a world leader in its efforts to eliminate hepatitis C and to improve the health of people who use drugs. But COVID-19, on a backdrop of economic uncertainty, anxiety and unemployment has the potential to disrupt our support, prevention and cure efforts – especially given the populations most impacted by hepatitis C and drug dependence are some of our most vulnerable Australians.
The 9th International Conference on Hepatitis Care in Substance Users will be held in Glasgow, Scotland, 8 – 10 October 2020.
The INHSU annual conference is a unique opportunity to connect with the global community working to improve health outcomes for people who use drugs including the prevention, treatment and care of hepatitis C.
This FREE one day conference, organised by Hepatitis Scotland, is aimed at staff who work in, or have strategic responsibility for, primary and secondary care addiction services.
The day will explore the background to developing successful hepatitis C case-finding initiatives, demonstrating real world successes and issues for practitioners to consider.
The 8th INHSU conference covers the latest advances on hepatitis C epidemiology, management and treatment of viral hepatitis among people who use drugs, with a specific focus on hepatitis C.
Through the dissemination of scientific knowledge, the conference aims to contribute to the World Health Organization’s goal of eliminating hepatitis C by 2030.
The 2018 European African HIV/AIDS & Hepatitis C Community Summit will take place in Amsterdam from 21-22nd July 2018.
Coordinated by the European African Treatment Advocates Network (ETAN) the event aims to work towards improved connection with immigrants in Europe to treat and prevent HIV and Hepatitis C.
